Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DDAH gene and cardiovascular risk.

Vascular medicine (London, England) - 1 Jul 2005

Valkonen Veli-Pekka, Tuomainen Tomi-Pekka, Laaksonen Reijo

Abstract excerpt

The crucial role of nitric oxide (NO) for normal endothelial function is well known. In many conditions associated with increased risk of cardiovascular diseases such as hypercholesterolemia, hypertension, abdominal obesity, diabetes and smoking, NO biosynthesis is dysregulated, leading to endothelial dysfunction. The growing evidence from animal and human studies indicates that endogenous inhibitors of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hypertension
Share to Mutation
Share to Polymorphism, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Share to Amidohydrolases

Share to Arginine

Share to Cardiovascular Diseases

Source

Identifiers

PMID: 16444868
DOI: 10.1191/1358863x05vm600oa

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DDAH gene and cardiovascular risk.PMID 16444868Read ↗

Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells.Semantic proximity Read ↗

Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease.Semantic proximity Read ↗

Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.Semantic proximity Read ↗

Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients.Semantic proximity Read ↗

A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.Semantic proximity Read ↗

Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.Semantic proximity Read ↗

DDAH1 promoter -396 4N insertion variant is associated with increased risk of type 2 diabetes in a gender-dependent manner.Semantic proximity Read ↗

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.Semantic proximity Read ↗

Association between variation in the genes DDAH1 and DDAH2 and hypertension among Uygur, Kazakh and Han ethnic groups in China.Semantic proximity Read ↗

Nitric oxide signaling in cardiac development, function and diseaseSemantic proximity Read ↗

Polymorphism (-499C/G) in DDAH2 promoter may act as a protective factor for metabolic syndrome: A case-control study in Azar-Cohort population.Semantic proximity Read ↗

Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.